Semaglutide for Weight Loss: What Miami Patients Need to Know

If you live in Miami and have been scrolling through Instagram lately, you have probably seen before-and-after photos tied to one word: semaglutide. What started as a diabetes medication has become one of the most talked-about weight loss tools in South Florida, and the questions coming into our Doral clinic have shifted from "does it work?" to "is it right for me?"

This guide is written for Miami patients who want a straight answer before they spend money or put a medication into their body. We will cover how semaglutide actually works, the difference between Ozempic and Wegovy, where tirzepatide (Zepbound and Mounjaro) fits in, what it costs here in South Florida, and the honest picture of side effects and candidacy.

What Semaglutide Is (and What It Is Not)

Semaglutide belongs to a class of drugs called GLP-1 receptor agonists. GLP-1, or glucagon-like peptide-1, is a hormone your gut already releases when you eat. It tells your brain you are full, slows how fast food leaves your stomach, and helps your pancreas release insulin at the right time. Semaglutide mimics that hormone, but it sticks around much longer than the version your body makes.

The result, for most people who take it, is a quieter relationship with food. Cravings soften. You feel satisfied on smaller portions. The constant mental noise about the next snack tends to fade. That effect is not willpower in a pen. It is a medication changing the underlying signals that drive hunger.

Semaglutide is not a fat-burner, not an appetite-pill gimmick, and not a substitute for basic health habits. Patients who lose the most and keep it off are the ones who pair the medication with protein-forward eating, strength training, and sleep.

Ozempic vs. Wegovy vs. Compounded Versions

This is where a lot of confusion starts, so let us be clear about the labels.

• Ozempic is semaglutide approved by the FDA for type 2 diabetes. Many doctors prescribe it off-label for weight loss, which is legal but not its on-label purpose.
• Wegovy is the same molecule, semaglutide, approved specifically for chronic weight management in adults with obesity or overweight plus a related health condition.
• Rybelsus is oral semaglutide, also approved for type 2 diabetes. It is less commonly used for weight loss because the injectable form tends to produce stronger results.
• Compounded semaglutide is made by specialty pharmacies and has been widely available during periods when brand-name supply was short. Quality varies significantly depending on the pharmacy, and the FDA has warned about certain non-approved "salt" forms. If a Miami clinic offers compounded semaglutide, ask where it is sourced and whether the pharmacy is 503A or 503B registered.

Where Tirzepatide and Zepbound Fit In

You have probably heard about Zepbound and Mounjaro too. Those are brand names for tirzepatide, a newer medication that acts on two hormone pathways (GLP-1 and GIP) instead of one. In head-to-head trials, tirzepatide has produced larger average weight loss than semaglutide for many patients. It is not "better" for everyone, though. Some patients tolerate semaglutide more comfortably, and insurance coverage is different for each drug. A good clinician helps you match the medication to your health history, your tolerance, and your goals, not to whatever is trendy that month.

How Much Weight People Actually Lose

Clinical trials for Wegovy showed average weight loss in the range of mid-teens percent of body weight over about 68 weeks, when the medication was combined with lifestyle changes. Tirzepatide trials have shown higher averages. Real-world numbers vary because real humans have jobs, families, travel, and holidays that trials do not.

Here is the realistic picture we share with Miami patients: many patients lose meaningful weight in the first three to six months, progress continues more slowly after that, and the final result depends heavily on whether the person also changes how they eat, move, and sleep. A small subset of patients do not respond much at all, and that is something we reassess around the 12-week mark.

Side Effects to Take Seriously

The most common side effects of semaglutide are gastrointestinal: nausea, occasional vomiting, constipation, diarrhea, and reflux. For most people these are worst in the first few weeks and after dose increases, and they settle down with time and small dietary adjustments. Eating slowly, cutting back on greasy food, and staying hydrated go a long way.

Less common but more serious concerns include pancreatitis, gallbladder problems, and, in rare cases, severe dehydration. Semaglutide is not recommended for anyone with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2. Pregnancy is another clear contraindication.

There has also been growing conversation about muscle loss on GLP-1 medications. When the body loses weight quickly, some of it can come from lean tissue. That is one reason we push Miami patients toward protein targets and resistance training while they are on semaglutide, not just cardio.

What It Costs in Miami

Cash price for brand-name Wegovy or Ozempic in South Florida pharmacies generally runs over a thousand dollars per month without insurance. Manufacturer savings programs exist for eligible patients and can bring that down substantially when a patient qualifies. Compounded versions are typically offered at lower monthly prices through medical weight loss programs, often bundled with clinic visits and lab work.

Insurance coverage for weight loss is the frustrating part. Many commercial plans still exclude anti-obesity medications even when they cover the same drug for diabetes. Before you commit to a program, ask the clinic to run a prior authorization or a benefits check so you know what you are actually signing up for.

Who Qualifies for Semaglutide

On-label, Wegovy is approved for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition like high blood pressure, type 2 diabetes, sleep apnea, or high cholesterol. That said, BMI alone does not tell the full story. We always consider body composition, medical history, and lab results before recommending any weight loss medication.

If you have a history of pancreatitis, certain thyroid conditions, severe gastroparesis, or you are pregnant or planning pregnancy, semaglutide is usually not the right call. The consultation is where that gets sorted out.

What a Real Medical Weight Loss Program Looks Like

Semaglutide is not a standalone product you should buy like a supplement. A responsible program in Miami should include:

• A full medical intake with labs (thyroid, A1C, metabolic panel, lipid panel)
• A plan for nutrition that keeps protein high enough to protect lean muscle
• Weight, waist, and body composition tracking, not just the scale
• Follow-up visits to adjust dose and catch side effects early
• A clear plan for what happens when you reach your goal weight

That last point is the one most clinics skip. Weight regain after stopping semaglutide is well documented. The plan has to include how you transition off, or whether you stay on a maintenance dose, and what lifestyle structure keeps the weight off long term.

Talking to a Doctor in Doral

At Viva Medical Center in Doral, we evaluate semaglutide and tirzepatide candidates as part of a full medical weight loss program, not a vending machine. That means an actual doctor reviews your history, your labs, your goals, and your budget before a prescription is written. If a different path makes more sense, we say so.

If you have been thinking about semaglutide and you want a straightforward conversation with a physician who treats Miami patients every day, you can reach our clinic at (305) 209-0001 or learn more about our medical weight loss program. Come in with your questions. The more you understand what you are doing and why, the better the result tends to be.

This article is for general education and does not replace medical advice. Always consult a licensed clinician before starting any prescription medication.